The baby malaria drug that took 20 years longer than expected
Why this story
Breakthrough targeting age group with highest death rate. Clear humanitarian impact with hundreds of thousands of lives at stake.
MAINSTREAM MEDICINE
First antimalarial designed for newborns unlocks UN funding for most at-risk group
ALTERNATIVE VIEW
Neem oil and traditional immunity-builders protected children before Big Pharma
RESEARCH FRONTIER
Next-gen drugs target multiple parasite stages; mosquito genetics trump single pills
Hidden Truth
Hidden truth: Artemether-lumefantrine has been available for adults since 2009, yet it took until 2026 to develop a baby-specific formulation — a 17-year gap that pharmaceutical companies…Read the full breakdown →
Should pharmaceutical companies be legally required to develop pediatric formulations within 2 years of adult drug approval?
More like this
World Politics676 Ebola cases, 140 dead — and the agency watching it is being dismantled
World Politics37 dead, 20,000 displaced — and Mindanao's buildings may be the real story
World PoliticsWHO cuts Congo Ebola count 90% as testing reveals mass misdiagnosis
World PoliticsThe Ebola variant spreading has no licensed vaccine yet
World Politics676 Ebola cases, 140 dead — and the agency watching it is being dismantled
World Politics37 dead, 20,000 displaced — and Mindanao's buildings may be the real story
World PoliticsWHO cuts Congo Ebola count 90% as testing reveals mass misdiagnosis
World Politics